MBX Biosciences Inc. Common Stock
MBX | NASDAQ
$61.31
+$0.37 (+0.61%)
Sep 22, 2026, 1:50 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 54.12M | 45.21M | 75.29M | 223.13M | 39.78M | 29.9M | 49.35M | 132.87M | 12.5M | 35.43M | 30.52M |
Short-Term Investments | 364.46M | 394.76M | 298.42M | 168.55M | 185.13M | 210.88M | 212.8M | 144.2M | 42.76M | 34.89M | 50.15M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 625K | 579K | 383K | 50K | 50K | 50K | 50K | 50K | 2.8M | 1.74M | 50K |
Receivables | n/a | 3.16M | 2.12M | 1.55M | 841K | 1.39M | 682K | 858K | 164K | 199K | 208K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.28M | 814K | 861K | 882K | 472K | 626K | 803K | 838K | 242K | 168K | 133K |
Total Current Assets | 427.86M | 448.54M | 381.54M | 397.5M | 229.19M | 244.28M | 267.29M | 281.17M | 58.8M | 72.7M | 83.47M |
Property-Plant & Equipment | 7.42M | 3.59M | 3.22M | 2.52M | 2.28M | 1.6M | 1.2M | 1.18M | 1.28M | 880K | 665K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.05M | 4.17M | 3.61M | 2.57M | 2.33M | 1.65M | 1.25M | 1.23M | 4.08M | 2.62M | 715K |
Total Assets | 435.91M | 452.7M | 385.14M | 400.08M | 231.52M | 245.93M | 268.54M | 282.4M | 62.88M | 75.32M | 84.18M |
Account Payables | 4.36M | 6.97M | 2.98M | 3.77M | 5.76M | 4.25M | 5.34M | 5M | 3.22M | 3.2M | 1.39M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 631K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 157K | n/a |
Other Current Liabilities | 23.03M | 2.33M | 4.32M | 2.78M | 2.14M | 1.23M | 2.32M | 1.85M | 1.12M | 1.57M | 1.37M |
Total Current Liabilities | 23.66M | 14.57M | 15.5M | 12.06M | 11.76M | 10.48M | 11.05M | 10.92M | 8.2M | 5.7M | 3.93M |
Long-Term Debt | 2.71M | 377K | 424K | n/a | n/a | n/a | n/a | n/a | n/a | 185K | n/a |
Other Long-Term Liabilities | n/a | 1K | 2K | 7K | 15K | 23K | 42K | 68K | 152.48M | n/a | 152.55M |
Total Long-Term Liabilities | 2.71M | 378K | 426K | 476K | 527K | 23K | 42K | 112K | 152.57M | 314K | 152.72M |
Total Liabilities | 26.37M | 14.95M | 15.92M | 12.54M | 12.28M | 10.5M | 11.09M | 11.03M | 160.77M | 6.01M | 156.65M |
Total Debt | 3.34M | 555K | 596K | 623K | 650K | 130K | 171K | 210K | 249K | 471K | 324K |
Book Value | 409.54M | 437.76M | 369.22M | 387.54M | 219.24M | 235.42M | 257.44M | 271.37M | -97.89M | 69.31M | -72.47M |
Book Value Per Share | 8.59 | 9.40 | 10.11 | 11.33 | 6.55 | 7.05 | 7.71 | 8.13 | -2.93 | 2.08 | -2.28 |
Common Stock | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 2K | 1K | 1K |
Retained Earnings | -285.09M | -247.99M | -224.48M | -202.41M | -180.8M | -161.39M | -137.51M | -121.92M | -103.78M | -87.92M | -75.58M |
Comprehensive Income | -1.22M | -606K | 286K | 154K | 11K | 53K | 55K | 106K | -15K | -3K | 60K |
Shareholders Equity | 409.54M | 437.76M | 369.22M | 387.54M | 219.24M | 235.42M | 257.44M | 271.37M | -97.89M | 69.31M | -72.47M |
Total Investments | 364.46M | 394.76M | 298.42M | 168.55M | 185.13M | 210.88M | 212.8M | 144.2M | 42.76M | 34.89M | 50.15M |
Add to Watchlist
Select watchlists to add or remove MBX